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The cell membrane acts as a primary barrier to the entry of 
macromolecules into cells. From a biotechnological per-
spective, the uptake of large macromolecules, in particular 
of plasmid DNA and RNA oligonucleotides, is highly desir-
able for gene manipulation purposes. Accordingly, various 
methods have been developed that allow the introduction of 
exogenous material to the cell. This process is generally 
referred to as transfection. There are two main categories 
for transfection. The first is reagent-based methods includ-
ing lipofection, calcium phosphate precipitation, cationic 
polymers, DEAE-dextran, activated dendrimers, and mag-
netic beads (Table 1). Reagent-based transfection methods 
use cellular uptake processes such as endocytosis and mac-
ropinocytosis or simply fusion of liposome particles with 
the plasma membrane (Fig. 1). The other method is instru-
ment based including biolistic technologies, microinjection, 
laserfection/optoinjection, and electroporation (Table 1). 
Virus-based methods are generally termed transduction, 
which is highly efficient for most cell types, including stem 
cells.1 Transduction is mechanistically and technically very 
distinct from direct gene transfer by transfection as it 
requires the production of encapsulated DNA or RNA in 
virus-like particles by an intermediate step and will not be 
discussed here in detail. In the scope of this review, we will 
focus on transfection for gene manipulation and large-scale 
high-throughput screening (HTS) studies.
Gene Manipulation
The human being contains a blend of many humors. When the 
humors are balanced, the human being is healthy, but when 
they are unbalanced or improperly mixed and one is more 
concentrated than the other, pain and disease is the result.2
—Hippocrates: On Ancient Medicine
To identify the function of a gene in a cellular process, the 
most common approach is to unbalance gene expression 
and observe the resulting effects. This can be achieved by 
gain-of-function approaches such as cDNA overexpression 
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Abstract
The discovery of RNA interference (RNAi) has enabled several breakthrough discoveries in the area of functional 
genomics. The RNAi technology has emerged as one of the major tools for drug target identification and has been steadily 
improved to allow gene manipulation in cell lines, tissues, and whole organisms. One of the major hurdles for the use of 
RNAi in high-throughput screening has been delivery to cells and tissues. Some cell types are refractory to high-efficiency 
transfection with standard methods such as lipofection or calcium phosphate precipitation and require different means. 
Electroporation is a powerful and versatile method for delivery of RNA, DNA, peptides, and small molecules into cell lines 
and primary cells, as well as whole tissues and organisms. Of particular interest is the use of electroporation for delivery 
of small interfering RNA oligonucleotides and clustered regularly interspaced short palindromic repeats/Cas9 plasmid 
vectors in high-throughput screening and for therapeutic applications. Here, we will review the use of electroporation in 
high-throughput screening in cell lines and tissues.
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or loss-of-function methods such as RNA interference 
(RNAi). The ultimate goal is to enhance or reduce, respec-
tively, the activity of a single gene or protein in cells in 
order to study their contribution to a cellular process or dis-
ease. Various methods that allow gene manipulation (Fig. 1) 
are described in more detail below.
Loss-of-Function Screening
RNAi. Screening for loss-of-function phenotypes typically 
requires the knockout or knockdown of an endogenous 
gene or protein. This can be achieved by transfection of 
short interfering (si) RNA oligonucleotides or short hairpin 
(sh) RNA–based plasmid vectors. RNAi has emerged as a 
powerful tool for loss-of-function screening, not least 
because siRNA libraries are commercially available in sev-
eral customizable formats and sizes. Genome-wide screens 
using siRNA libraries have provided valuable insights into 
cellular factors required for virus infection,3 endocytosis,4 
and regulation of mitosis,5 just to name a few. Both siRNA 
and shRNA use double-stranded RNA molecules that lead 
to sequence-specific degradation of mRNA in the target 
cells.6 When sequences within the genome show partial 
complementarity to the seed region (nucleotides 2–8), the 
siRNA/shRNA can exert quite significant off-target 
effects.7,8 Computational methods and chemical modifica-
tions to the siRNA oligonucleotides have made significant 
improvements to reduce off-target silencing.9 The effi-
ciency of RNAi also depends on multiple other parameters 
such as the half-life of the mRNA, the amount of mRNA, 
and the localization in the cell.
Table 1. Transfection Methods.
Method Mechanism Advantage Disadvantage
High-Throughput 
Screening?




Cheap; high efficiency Not applicable to all 
cell types; reagent 
consistency; does not 
work in RPMI medium
Yes
Cationic lipids (e.g., 
lipofectamine)
Lipids merge with 
membrane
Cheap; high efficiency Not applicable to all cell 
types
Yes
Cationic polymers (e.g., 
PEI, DEAE-dextran, 
dendrimers)
Endocytosis or  
macro-pinocytosis
Cheap Not applicable to all cell 
types
Yes
Magnetofection Magnetic force Rapid; high efficiency Adherent cells only No
Electroporation Membrane pores High efficiency Cost; cell toxicity Yes
Biolistic particle delivery Targeted delivery; cell 
type independent
Low efficiency; cost No





Laser light to permeabilize 
cell membrane
Works for many cell  
types and substances
Cost; adherent cells only; 
technically demanding
No
Soaking Easy Drosophila only Yes
Feeding Sid-1 transporter Easy Worms Yes
Figure 1. General gene delivery mechanisms. (A) Electroporation. 
During electroporation, cell membranes are destabilized allowing 
nucleic acid entry into the cell. (B) Reagent-based techniques. The 
reagents used form complexes with the negatively charged nucleic 
acids, which are then taken up by the cell via endocytosis. Reagents 
include cationic lipids, cationic polymers, and calcium phosphate. 
Cationic lipids form liposomes, which will fuse with the cell 
membrane and endosomes causing the release of the nucleic acids 
into the cytoplasm. Cationic polymers such as polyethylenimine 
condense nucleic acids. They act as a proton sponge, thus buffering 
acidic endolysosomes and possibly causing their rupture. How 
calcium phosphate/DNA precipitates are taken up and released 
into the cytoplasm is not well understood so far. (C) Biolistic 
particle delivery. Nucleic acid–coated gold particles are shot at 
target cells. (D) Microinjection. Via an injection needle, nucleic 
acids can be directly delivered into the nucleus or cytoplasm. Less 
frequently used methods to deliver genetic material into cells like 
magnetofection or laserfection as well as viral transduction methods 
are not displayed.
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Efficient delivery of the siRNA or shRNA to the cyto-
plasm is a prerequisite for efficient knockdown of the target 
gene. In Caenorhabditis elegans, dsRNA is taken up 
through a membrane channel transporter called sid-1.10 In 
Drosophila, uptake of dsRNA is mediated by endocytic or 
phagocytic routes.11 In most other cells and organisms, 
large charged molecules do not cross the cell membrane 
easily, and specialized methods for gene delivery are 
required. A common siRNA delivery method is electropora-
tion, which will be discussed in detail further below.
Genome editing. Alternative methods for loss-of-function 
screening rely on genome-editing technologies such as zinc 
finger nucleases, transcription activator-like effector nucle-
ases, or clustered regularly interspaced short palindromic 
repeats (CRISPR). Of these, CRISPR/Cas has emerged as a 
powerful tool for the generation of large-scale HTS 
libraries.12
CRISPR are DNA loci with repetitive sequences that act 
as a primary defense against invading pathogens in some 
bacteria and most archaea. This acquired immunity provides 
defense against plasmids and phages through the activation 
of CRISPR-associated Cas genes, resulting in endonuclease-
mediated cleavage of the foreign DNA sequence.13 The 
CRISPR/Cas system has recently been adapted to become an 
efficient tool for genome engineering.14–16 This simple 
genome-editing system allows the generation of gene knock-
outs/knockins, transgenes, and modification in a much 
shorter time frame than alternative methods. The CRISPR/
Cas system requires three components: the Cas endonucle-
ase, a crRNA that targets the Cas nuclease to the desired 
genomic location, and a tracrRNA that mediates complex 
formation of the crRNA with the Cas protein. Similar to 
siRNA, a short RNA sequence of 20 nucleotide length pro-
vides sequence specificity. There are conflicting studies 
reporting variable degrees of off-target effects,17–19 with some 
labs claiming that off-target effects are almost absent when 
the guide RNA (gRNA) are properly designed. Several 
groups have recently reported the generation of large-scale 
libraries with sequence-specific gRNAs for high-throughput 
screening applications.20–23 To date, only libraries of pooled 
lentiviral vectors exist, which have limited use in positive or 
negative selection screens. Efforts are under way to generate 
arrayed libraries, which will broaden the range of potential 
applications in high-content and high-throughput phenotypic 
screening.
Gain-of-Function Screening
cDNA overexpression. Arrayed cDNA libraries are available 
from various commercial vendors for human and mouse 
genes. Some libraries are available as expression-ready 
clones, often with attached tags for detection such as Flag, 
myc, or green fluorescent protein (GFP). Others, such as the 
ORFeome collection, are available as gateway clones that 
allow easy manipulation of the vector and introduction of 
modifications such as tags or other fusion proteins. To date, 
almost the entire human and mouse genome are available 
from commercial vendors (e.g., Origene, ThermoFisher), 
although a few clones and variants remain to be identified 
and added to these collections. Most libraries are partially 
sequence verified. The principle of cDNA expression relies 
on a deliberate increase in copy numbers for one gene. His-
torically, cDNA expression cloning has been highly success-
ful in identifying virus and growth factor receptors.24 For 
organisms in which arrayed libraries are not commercially 
available, they can be generated by cDNA amplification of 
mRNA, as it has been historically done to create the so-called 
“million clone” libraries. Some of the caveats of cDNA over-
expression include the difficulty of controlling the expression 
level of the encoded proteins, promoter interference, and 
mosaic expression in cells or tissues. Nonetheless, cDNA 
expression libraries are very powerful tools to study gene 
function in a large-scale screening format, as well as to com-
plement and rescue siRNA loss-of-function experiments. 
Furthermore, bacterial artificial chromosome expression 
libraries may help overcome some of the mentioned artifacts 
associated with cDNA expression.25
CRISPR activation. Recently, an alternative to cDNA overex-
pression for gain-of-function studies that uses CRISPR-
mediated genome editing has been developed. This approach 
relies on the activation of specific target genes through DNA-
guided transcriptional enhancers,26–31 and it has been used 
with genome-wide CRISPR activation libraries. The group of 
Jonathan Weissmann generated a library of gRNAs both for 
inactivation and activation of transcription.32 Feng Zhang’s 
group synthesized 70,290 gRNAs targeting all human Ref-
Seq coding genes.33 Most gRNA libraries require transfection 
of a plasmid DNA, and it remains to be seen whether gRNA 
oligonucleotide transfection can also serve to mediate 
CRISPR/Cas genome editing.
All of the above-described gene manipulation approaches 
including si/shRNA, cDNA, and CRISPR-based methods 
require efficient delivery of plasmid DNA or RNA oligonucle-
otides to cells by transfection.
Gene Delivery Methods
The main methods for gene delivery are based on chemical or 
lipofection reagents (Table 1). Chemical methods are partic-
ularly cheap and generally achieve high transfection efficien-
cies in standard transformed cell lines such as HEK293 or 
COS cells. However, these methods work much less effi-
ciently in primary cells and a large number of cancer cell 
lines. Lipofection-based methods are very efficient for intro-
duction of foreign material into a large number of cell types. 
There are some limitations regarding the transfection of 
Luft and Ketteler 935
primary cells. Other methods such as ballistic transfection, 
magnetofection, and microinjection are less commonly used 
as they require a specialized technical setup and high levels 
of training. These methods are generally not amenable to 
HTS approaches as they cannot be standardized into robust 
automated assays. Electrical methods work very well for a 
large number of cell types. Recently, electroporation instru-
ments have become available to enable the standardized elec-
troporation in multiwell plates, thus making it possible to use 
this method in HTS applications.
In general, transfection methods impose a stressful con-
dition to cells. Common artifacts resulting from transfec-
tion are the induction of autophagy in many cell lines,34 
interference with translation mechanisms, and an induction 
of an interferon (IFN) response on shRNA transfection in 
mammalian cells.35 For instance, in bovine bone marrow–
derived macrophages, most lipofection-based methods 
resulted in an induction of an IFN response, whereas elec-
troporation was not only superior in terms of transfection 
efficiencies but also very importantly did not induce an IFN 
response.36 It remains to be shown whether electroporation 
in general presents fewer side effects on cellular processes, 
although it should be noted that electroporation can result in 
some degree of toxicity and associated phenomena.
Electroporation
The use of electrical impulses on cells dates back to early 
studies by Neumann and Potter on mouse myeloma cells.37–39 
More recently, electroporation has been recognized as a 
powerful method to deliver plasmid DNA and siRNA oligo-
nucleotides into cells that are otherwise difficult to trans-
fect. For instance, electroporation has been successfully 
used to deliver cDNA plasmids and siRNA oligonucleotides 
into T cells,40 hMSC, NHA, NDHF-neo, human umbilical 
vein endothelial cell (HUVEC), DI TNC1, RPTEC, PC12, 
and K562 cells.41
The three main effects of applying an electrical field to 
cells—depending on the strength of the electric field—are 
(1) the formation of pores in the membrane(s), (2) the 
movement of cells in dielectrophoresis, and (3) cell fusion. 
The formation of pores will facilitate uptake of macromol-
ecules in cells.
The basic principle underlying all of these experiments 
is that brief, high-intensity electrical pulses will create tran-
sient pores in the membrane of cells. When the electrical 
pulses are turned off, the membranes reseal, which is essen-
tial for survival of the cells. It can be imagined that opening 
and resealing provide a condition wherein large macromol-
ecules can enter and exit the leaky cell. Thus, the duration 
and spacing of pulses, as well as the intensity, are crucial for 
high levels of uptake of macromolecules in cells. In addi-
tion, the geometry of the electrodes will determine the elec-
trical field applied to a cell monolayer or three-dimensional 
structure and is therefore critical for successful gene deliv-
ery. The main parameters that determine electropermeabil-
ity are the following:
•• cellular factors such as cell density, cell architecture, 
and cell biochemistry;
•• physicochemical factors such as temperature, pH, 
osmolarity, and ionic concentration of the buffer 
used; and
•• electrical parameters such as electrical field strength, 
voltage, pulse length, pulse number, and electrode 
geometry.
The selection of appropriate buffers used for electropor-
ation will also affect the efficiency of gene delivery. Main 
parameters for selecting the right buffer are osmolarity and 
ionic strength, while maintaining the highest possible sur-
vival rate. Buffers that mimic intracellular ionic strength 
have been generally recommended,42 but in general, most 
standard media work reasonably well. Improvements to 
media compositions aim to enhance cell survival postelec-
troporation so that harsher electroporation parameters can 
be used. Electroporation conditions for each cell type will 
therefore be slightly different, but there are some general 
guidelines and principles that we will outline below.
Principle
The basis for all electrochemical manipulations of cells is 
the formation of a polarized cell in an electric field (Fig. 
2). This occurs as a consequence of the interaction of an 
electrical field with charges on the cell surface and interior 
of the cell. Accordingly, the cellular membrane will 
impose a restriction on the movement of charges in an 
electrical field and thus lead to polarization of the cell 
when placed between two electrodes. This polarization of 
the cell can result in motions in the cytoplasm leading to 
structural rearrangements or mechanical fracture. Cell 
membranes have low polarizability with a dielectric con-
stant of about 2 and low conductivity (~1 nS/cm), whereas 
the surrounding media have a high dielectric constant 
(around 80) and high conductivity (about 0.1 S/cm).43 The 
application of an electrical field will result in high move-
ment of ions in the surrounding media and accumulation at 
the membrane surface, thus leading to polarization. This 
in turn will create an electrical field inside the cell that can 
be of much higher strength than the field in the surround-
ing media and thus lead to the formation of pores resulting 
in discharge of the charges at the membrane. The basic 
relationship to calculate the voltage across a membrane in 
a spherical object is estimated as
V V t= − −m p1  exp[ ( / )]τ (1)
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where Vm is the maximum transmembrane voltage, τ is the 
duration of the pulse, and tp is the polarization time.
44 For 
spherical membranes of radius R, Vm and the time constant 
tp are
V ERm  15 cos = . δ
t RC r rp i o= +( )m  50.
where δ is the angle between the electric field, E; the radius 
vector, Cm, is the membrane capacitance; ri and ro are resis-
tivities inside and outside the cell; and the membrane con-
ductance is neglected. In this equation, the cell radius 
directly correlates with the strength of the electrical field 
that needs to be applied. Larger cells can be electroporated 
with smaller strength E than smaller cells. For instance, at 
the poles (δ = 0), the induced transmembrane voltage is 
maximal. Another important parameter is the charging time 
tp, which should always be smaller than the pulse duration 
τ, as nanosecond pulses with high electric fields typically 
result in cell killing.45 A detailed strength-duration map has 
been formulated that predicts the outcome of varying these 
parameters.46 For instance, cells with higher resistance and 
larger cell radius require longer pulse duration times.
The above equations consider cells as spherical objects 
for simplicity. The transmembrane voltage for a nonspheri-
cal, ellipsoid, or cylindrical cell in an arbitrarily oriented 
position can be described by
V n aa a 1 1 E= −( )/
where a stands for the semiaxis oriented in field direction 
and na for the depolarizing factor along semiaxis a.
47 More 
complex cell shapes are described elsewhere.48
Membranes are electroporated when the transmembrane 
voltage V exceeds a critical threshold, which is typically in 
the range of several hundred mV to 1 to 2 V. Generally, an 
increase in the pulse duration equates to a decrease in the 
voltage required. It should be noted that the application of 
electrical fields results in heating of the sample, and cooling 
has been recommended to improve cell survival. Therefore, 
Figure 2. Electroporation of cells. Electroporation occurs through four main steps: (1) polarization of the cell, (2) rapture of the 
membrane creating nanopores, (3) entry of the macromolecules, and (4) resealing of the membrane. (1) Application of short electrical 
pulses will result in membrane charging, creating an electrical field and resulting in polarization of the cell. The strong electrical 
field will result in structural rearrangements of the membrane, creation of water-filled membrane structures (“aqueous pores”) and 
“nanopores” with a size of more than 1 nm that allow ionic transport. (2) Larger pores are formed in the membrane that allows 
influx of macromolecules such as DNA or RNA. Generally, more pores are formed at the site facing the negative electrode. (3) Large 
macromolecules can enter the cell. The negative charge of DNA/RNA can act as a drag to enhance uptake, although, on the other 
hand, positive ions such as calcium can enhance proximity to the negatively charged membrane prior to uptake. (4) Electroporation is 
reversible, and once the electric field is switched off, the membrane has the capacity to reseal and keep the macromolecules inside the 
cell. Resealing occurs on a much longer time frame (minutes to hours), whereas pore formation can occur within milliseconds. Low 
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increases in temperature (e.g., due to increased field 
strength) will require shorter pulse duration.46
Another important consideration is the kinetics of pore 
opening and resealing. Typically, pore formation occurs 
within microseconds and initial recovery of the cell mem-
branes within milliseconds. Complete recovery may take 
much longer (i.e., seconds, minutes, or even hours). Longer 
pulses produce larger pores, and very long pulses and/or 
high voltages will lead to irreversible membrane damage. It 
has been noted that pore formation and electroporation of 
large molecules into cells can be asymmetric with higher 
permeation on the one electrode side, an effect that is depen-
dent on the salt concentration of the buffer used.49
For negatively charged molecules, such as siRNA oligo-
nucleotides, it was noted that the electric field acts both to 
permeabilize the cell membrane as well as to provide an elec-
trophoretic “drag” of the negatively charged siRNA molecule 
from the bulk phase into the cytoplasm.50 Therefore, there 
may be an advantage for delivery of charged molecules by 
electroporation. Similarly, it was noted that electroporation 
of crude DNA preparations were more efficiently transferred 
to cells than purified CsCl2 preparations because of a carrier 
effect of the contaminating bacterial RNA.51
The first demonstration that electroporation could be 
used for transfection and expression of a foreign gene was 
made in 1982, and the term electroporation was coined.38 
Since then, electroporation has been used for multiple cell 
types, including cell lines, primary cells, plant cells, and 
single-cell organisms. Electroporation can also be used to 
introduce genes in whole tissues or organisms.
The application of electrical pulses to cells can also lead 
to another phenomenon called electrofusion, whereby two 
adjacent cell membranes fuse with each other, thereby gen-
erating multinucleated cells. For electrofusion to occur, the 
membranes must be in close proximity. The most efficient 
way to ensure whether either fusion or permeabilization 
occurs is by reducing the cell density in a sample prepara-
tion. As low cell density is often associated with a higher 
vulnerability of the cells to stress, this poses a challenge for 
efficient electroporation protocols.
In Vivo Electroporation
An exciting and growing area is the use of electroporation 
in vivo for delivery into tissues and whole animals. 
Electroporation has been achieved in complex models. 
Examples include the electroporation of DNA in mouse 
testis,52 the subretinal space,53 and zebrafish forebrain.54 
Other applications include the delivery of shRNA plas-
mids and siRNA oligonucleotides in skeletal muscle,55 
kidney glomeruli,56 the developing cerebella,5, and in vivo 
solid tumors.58
When using electroporation in tissues such as solid 
tumors, the electrical field and transmembrane voltage will 
be dependent on the tissue architecture and microenviron-
ment of the cells.59,60 For instance, it was observed that the 
electric field in cells surrounded by other cells can be 
reduced by as much as one-third compared with single cells 
in suspension.61 In general, efficiency of electrotransfer in 
tissues is relatively low with only a few percentage of trans-
fected cells62 that are mostly found in the periphery of a 
tumor.63 To gain insight into these phenomena, electropora-
tion in simpler three-dimensional (3D) model systems such 
as spheroids has been studied.64 Interestingly, although inte-
rior cells in such spheroid models can be efficiently per-
meabilized, the uptake of large macromolecules such as 
DNA is generally limited to the outer layers, probably 
because of inefficient transport across longer distances.61,64 
It was proposed that low voltage but long pulses may be 
able to electrophoretically push the DNA toward the center 
of a spheroid or tissue.
Typically, needle electrodes are used for in vivo electro-
poration, sometimes in combination with ring-shaped or 
plate electrodes. The overall arrangement of the electrodes 
will greatly affect the electroporation efficiency. Recently, a 
three-electrode system was designed for efficient electro-
poration in utero of neural cells.65 The triple-electrode 
arrangement allowed testing changes in electrical field dis-
tribution, which overall enhanced the transfection effi-
ciency in rat Purkinje cells.
Electroporation in tissues and 3D model systems is an 
intense area of research and will find applications in clinical 
and preclinical use.
Applications of Electroporation in HTS
The instruments for electroporation require only two com-
ponents: a high-voltage pulse generator and two electrodes 
embedded in the cell suspension. Table 2 summarizes elec-
troporators for multiwell plate format from various sources.
There are several requirements for electroporation in a 
high-throughput format: first and foremost, the instrument 
has to enable an efficient processing of multiple samples in a 
short time frame, requires minimal manual steps involved in 
electroporation, and has to be cost-effective and minimize 
volumes of the transfected material. Typically, relatively 
large volumes are required for cuvette-type transfections, and 
therefore, multiple vendors have designed microplate elec-
troporation instruments. Most of these use sequential pro-
cessing of samples (siPorter96, Nucleofector) and thus 
require a relatively long time for completion from the first to 
the last well. The BTX allows processing of eight samples in 
parallel, and the Cellaxess and Primax iPorator96 are instru-
ments that allow processing of 96 samples in parallel. Only 
two instruments allow transfection in 384-well plate format 
(Cellaxess and Nucleofector 4D). Another factor is that 
because of the arrangement of the electrodes, most instru-
ments enable transfection of cells in suspension (with the 
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exception of the Cellaxess), making this impractical for 
applications in which adherent cell differentiation is required 
(e.g., induced pluripotent stem cell [iPS]–derived neurons).
To date, very few applications of electroporation in high-
content and phenotypic screening have been published. 
Although a number of electroporation devices are available 
for the use in 96-well and 384-well plate format, work has 
been focused on establishing and optimizing protocols for 
the electroporation of otherwise difficult-to-transfect cells. 
In particular, it has been proposed that electroporation can 
facilitate phenotypic screening using siRNA and cDNA 
libraries in difficult-to-transfect cell lines such as neurons, 
stem cells, and macrophages.
Primary neuronal cultures as well as neurons derived 
from iPS cells are an essential model to study molecular and 
biochemical processes involved in neurogenesis, neuronal 
function, and plasticity as well as neurodegenerative dis-
eases. Postmitotic and differentiated neurons, however, are 
challenging to transfect. Their elongated neurites and their 
sensitivity to physical stress, alterations in temperature, pH 
shifts, and changes in osmolarity contribute to low transfec-
tion efficiencies (reviewed in refs. 66–68). Thus, protocols 
are needed that boost efficiency while keeping toxicity to a 
minimum. Optimization protocols for potential RNAi and 
cDNA library screening were performed using a variety of 
instruments, which are based on two main approaches: the 
electroporation of cells in suspension directly on the isola-
tion of neurons or neuronal progenitor cells and the electro-
poration of adherent neurons in culture. Examples for 
transfection of neurons in suspension include nucleofection 
with the Lonza Nucleofector and transfection with the sys-
tem provided by BTX Havard Apparatus. Optimization pro-
tocols for both instruments are available. For example, 
successful transfection of rat neurons has been done using 
the BTX system.69 Hutson et al.,70 who isolated cerebellar 
granule neurons from rat pups (P7-9), transfected the 
obtained neuronal suspension with cDNA using a 96-well 
electroporation plate, the HT-200 plate handler, and the 
ECM 830 square-wave pulse generator by BTX Harvard 
Apparatus and plated the transfected neurons thereafter. 
The pulse parameters of one pulse at 300 V and 1 ms length 
resulted in 28% transfection efficiency and 51% viability. A 
similar study was performed by Buchser et al.69 using the 
same setup and comparable high pulse voltage (340 V) and 
short pulse length (900 µs). Another protocol, describing 
the transfection of freshly isolated embryonic rat and mouse 
hippocampal neurons with the Lonza Nucleofection 96-well 
shuttle system was published by Zeitelhofer et al.71 The 
Nucleofection system also uses short high-voltage pulses to 
ensure high transfection efficiency.
Electroporation of adherent neurons provides several 
advantages such as enabling the use of in-plate differentia-
tion protocols, reduced toxicity, and the ability to perform 
high-content imaging without subjecting the cells to stress-
ful detachment and reseeding. The Cellaxess Elektra system 
enables transfection of adherent neuronal cultures in a 384-
well format. It was shown that the capillary electroporation 
concept of the Cellaxess Elektra allows the successful 
transfection of hippocampal and cortical neurons, which 
were isolated from rat brains (E18) and subsequently cul-
tured for 5 d to allow axon and dendrite development.72 In 
this study, two short 2 ms pulses at 350 V resulted in 30% of 
GFP-positive neurons when a GFP plasmid was used for 
transfection and a significant reduction of GFP when siGFP 
was co-transfected. Cell viability was not impaired compared 
with nonelectroporated samples. Higher voltage pulses 
yielded higher transfection efficiencies of up to 50% with 
viabilities still greater than 85%.
Besides neurons, human embryonic stem cells (hESCs) 
have been proven difficult to transfect. hESCs are derived 
from blastocyst-stage embryos, are able to proliferate con-
tinuously. and can differentiate into any cell type.73,74 Other 
studies have shown that the transfection efficiency with 
chemical reagents such as Lipofectamine, Fugene, or Exgen 
500 is very low.75,76 Electroporation protocols result in a 
slightly more efficient transfection, but parameters need to 
be optimized to avoid substantial cell death. Nucleofection 
seems to deliver good transfection and viability results and 
was optimized for the use in 96-well plate format, as shown 
by Moore et al.77 They transfected various undifferentiated 
hESC lines with only a loss of about 25% due to cell death. 
The variability of the transfection efficiency between exper-
iments was high, ranging from just greater than 20% to 
three-quarters of cells being transfected. The nucleofection 
shuttle system was also used in a microRNA (miRNA) 
screen to identify miRNAs involved in the regulation of 
Table 2. Selected Instruments for High-Throughput Electroporation in Multiwell Formats.
Instrument Model No. of Parallel Processing Plate Type Comments/Web Site
Cellectricon Cellaxess Elektra 96 384 well www.cellectricon.com
Lonza/Amaxa Nucleofector 1 96 or 384 well www.lonza.com
Harvard Apparatus BTX830 8 96 well www.btxonline.com
BIORAD GenePulser MXcell Flexible 96 well www.bio-rad.com
Primax iPorator-96 96 96 well www.primaxbio.com
Ambion siPORTer96 1 96 well  
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hematopoiesis.78 For this screen, H9 hESCs were differenti-
ated into common myeloid progenitor cells. Cells were then 
transfected with the pre-miR miRNA precursor library-
human V3 and cultured for 4 to 5 d in 96-well plates before 
flow cytometry analysis revealed the impact of various 
miRNAs on hematopoiesis.
Differentiated macrophages have also been shown to be 
possible target cells of siRNA screening with the 96-well 
shuttle system.79 A pilot screen was described in which a set 
of siRNAs was investigated regarding their ability to regu-
late lipopolysaccharide-induced cytokine production. In 
this preliminary study, fluorescein isothiocyanate–labeled 
siRNA was used to show the high transfection efficiency.
Another study used nucleofection in otherwise hard-to-
transfect HUVECs to identify genes that regulate cell via-
bility.80 The viability assays were performed 72 h after 
nucleofection with the Dharmacon Human siGenome 
SMART pool siRNA libraries for protein kinases and cell 
cycle regulation.
Overall, electroporation in high-throughput format is 
feasible but has not been taken up by the scientific commu-
nity. The main reason for this is the associated cost. The 
business strategy for all commercially available instruments 
relies on the purchase of proprietary buffers and plates at a 
very high cost. This makes the application of all commer-
cial electroporation instruments impractical for large-scale 
screening. This is highly surprising as it defeats the purpose 
of an instrument that was built for large-scale applications.
For this reason, several academic laboratories have 
explored the design and engineering of electroporation sys-
tems that circumvent these problems. Design of a custom-
ized electroporator is relatively simple, as it only requires 
two main components: a high-voltage pulse generator and 
two electrodes embedded in a cell suspension. The two 
main types of customized systems are (1) flow electropora-
tion chips and (2) suspended drop-based electroporation 
systems in a 96-well microplate format.
Flow-based systems enable a rapid transfection of a 
large number of cells in a continuous or semi-continuous 
flow.81 Generally, these systems are used when a large 
number of cells are needed, for instance, in clinical 
research. On the contrary, when a large number of samples 
are interrogated, microplate-based electroporation sys-
tems are required.
A 12-well electroporation prototype plate was developed 
that uses interdigital electrode arrays for efficient electro-
poration of siRNA and plasmid DNA in cell lines and pri-
mary cells, and a 96-well design that is compatible with 
standard microplate formats was proposed.82 Another sys-
tem that allows high-throughput electroporation enabling 
parallel electroporation of spotted siRNAs in microwell 
arrays has been described recently.83 The surface of the 
arrays is functionalized with amine groups so that coupling 
of siRNA molecules and parallel electroporation in one 
microwell chamber is possible. siRNAs were spotted in a 9 
× 9 array using automated noncontact inkjet printing, and 
cells were electroporated quickly after seeding into the 
chamber. In principle, this system allows a high-throughput 
electroporation of thousands of siRNAs in a miniaturized 
array format.
A suspended drop-electroporation system has been pre-
sented that allowed high-efficiency transfection of cell lines 
and primary cells in a microplate format.84 This system uses 
suspended electrode pairs in a 96-well microplate format 
for top loading of samples, thus allowing the use of robotic 
liquid handling and parallel processing of 96 samples. 
Buffers that can be used are very cheap standard media. 
This system enables electroporation of DNA, siRNA, and 
small molecules at a low cost in a very short time frame.
A similar device for top loading of cells into through-
holes of a pair of gold-coated electrodes was described 
recently.85 In this system, the 96-well electrode array is 
placed on top of standard microplates, allowing the ejection 
of cells into the bottom plate by straightforward addition of 
cell media. All 96 samples are electroporated in parallel, 
and each well can be addressed separately, representing a 
very flexible and modular system. Such systems will enable 
the development of simple 96-well electroporation plates as 
cheap consumables that can be placed on top of any receiver 
plate. This will be a step forward toward realizing a modu-
lar approach for high-throughput electroporation. The user 
could then select a receiver plate of choice suitable for bio-
chemical assays or with optically clear bottom for high-
content screening. It can be expected that these systems will 
replace the traditional plate-based inflexible formats of cur-
rent commercial vendors.
Electroporation has historically been considered as the 
last straw when other transfection methods have failed. 
Although electroporation instrumentation for HTS is now 
readily available, access to microplate-based electropora-
tors and the high consumable cost are still major hurdles to 
implement this in the wider community. Given that this is 
such a powerful method, maybe it is time to rethink the 
business strategy in this area.
We have observed that most major cell types including 
primary cells can be easily transfected by electroporation. 
Given the higher physiological relevance of these models, it 
can be expected that the implementation of large-scale elec-
troporation will increase in the coming years.
Interesting areas to watch are the further development of 
high-throughput electroporation devices that are either 
based on flow chips or suspended drop systems. Also, the 
use of flexible material for supporting the electrodes such as 
parylene allowing embedding of target cells/tissues within 
the electrodes will become extremely valuable for physio-
logically relevant systems and in vivo electroporation.86
It can be expected that these and other developments will 
facilitate large-scale screening in the future. Especially for 
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the emerging CRISPR technology, this will be important as 
most CRISPR-based methods to date require plasmid-based 
transfection or transduction.
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